mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.06 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.06 |
mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
0.061 |
0.06 |
mRNA |
JQ12 |
GDSC1000 |
pan-cancer |
AAC |
0.07 |
0.06 |
mRNA |
MPS-1-IN-1 |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.073 |
0.06 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.06 |
mRNA |
STF-62247 |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.07 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.07 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.07 |